Bumble (BMBL) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BMBL Bumble

Watchlist

7.080
-0.050-0.70%

Close Oct 31 16:00 ET

7.080
0.0000.00%

Post 20:02 ET

895.90MMarket Cap20.82P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Preview: Bumble to Report Financial Results Post-market on November 06
Moomoo News21:00 ET
BofA Securities Maintains Bumble(BMBL.US) With Sell Rating, Maintains Target Price $5.5
Moomoo NewsOct 30 10:31 ET · Ratings
Is It Too Late To Consider Buying Bumble Inc. (NASDAQ:BMBL)?
Yahoo FinanceOct 17 08:51 ET
Bumble Inc. to Announce Third Quarter 2024 Financial Results on November 6, 2024
BusinesswireOct 16 16:05 ET
The Returns On Capital At Bumble (NASDAQ:BMBL) Don't Inspire Confidence
Simply Wall StOct 16 10:52 ET
The Most Crowded Longs and Shorts in Internet – Jefferies
Seeking AlphaOct 14 10:44 ET

Comments

Movers and Shakers

Sep 27 07:36

Columns Today's Pre-Market Movers and Top Ratings | COST, DG, BMBL, HPQ and More

Morning Movers
Gapping up
$Bristol-Myers Squibb (BMY.US)$ Shares jumped 3.8% after the FDA approved Cobenfy as a new treatment for schizophrenia in adults, marking the first novel treatment for the mental disorder in several decades.
$Wynn Resorts (WYNN.US)$ Shares climbed 1.7% following an upgrade to overweight from equal weight by Morgan Stanley, which highlighted the company's strong fundamentals compared to its competitors...

Expand

jimmy the trader

Aug 26 09:44

Any reason why you’d think this company would recover?

$Bumble (BMBL.US)$

Stock_Drift

Aug 18 06:01

💸💸💸💸💸
$Bumble (BMBL.US)$

Kevin Travers

Aug 8 10:24

Columns Earnings Bite Consumer Stocks, Besides Weightloss | Moovin Stonks

Good morning, traders. Happy Thursday, the market is trying to climb up after falling back. The Nasdaq and tech stocks were still in correction territory from their heights in the lush days of July. My name is Kevin Travers, here are moovin' stonks.
Eli Lilly $Eli Lilly and Co (LLY.US)$ posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...